Log In
BCIQ
Print this Print this
 

SGX101

  Manage Alerts
Collapse Summary General Information
Company Soligenix Inc.
DescriptionAntibacterial against Burkholderia pseudomallei
Molecular Target
Mechanism of ActionVaccine
Therapeutic ModalityPreventive vaccine
Latest Stage of DevelopmentPreclinical
Standard IndicationBacterial infection
Indication DetailsTreat meliodosis
Regulatory Designation
PartnerIntrexon Corp.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today